Which hedge funds own KLRS? KALARIS THERAPEUTICS INC, Q2 2026 13F holders

14 tracked hedge funds disclosed a position in KLRS (KALARIS THERAPEUTICS INC) in their Q2 2026 13F filings, worth $12.7m in total. The largest holder by portfolio weight is Verdad Advisers, LP at 0.3% of its book. 3 opened a new position this quarter: Verdad Advisers, LP, Trexquant Investment LP, Citadel Advisors LLC. 5 exited: Propel Bio Management, LLC, Paradigm Biocapital Advisors LP, 683 Capital Management, LLC.

14

Holders

Tracked managers whose filing for the quarter reports a long equity position in the security.

3

New this quarter

Holders whose previous filing (at most two quarters earlier) did not report the security.

5

Exited this quarter

Tracked managers whose previous filing reported the security and whose filing for the quarter does not.

$838k

Inflow, new holders

Combined value of the positions the new holders reported for the quarter.

$6.4m

Outflow, exits

Combined value the exiting managers reported for the security in their previous filing.

$12.7m

Combined value

Sum of the holders' reported positions in the security.

1.1%

Share of managers holding

Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.